GVC Gaesco Beka, S.V., S.A.
BDO AUDITORES, S.L.
CL/ VELAZQUEZ 24, 28001 MADRID
|2016||2017 until 15/12|
Period Close Price
Period Last Price
Period High Price
Period Low Price
"ATRYS Health specializes in innovative medical diagnostic imaging.and personalized cancer diagnosis and treatments in advanced single-dose radiation therapy company. Our commitment to R & D puts us at the forefront of individualized medicine ."
ATRYS is an innovative company dedicated to providing diagnostic services and medical treatments of excellence, combining technical diagnostic accuracy in pathological and molecular and diagnostic anatomy online image through its own technological platform multi-specialty, with new radiation oncology treatments.
ATRYS aims to apply the most advanced methods of diagnosis and treatment of cancer. The commitment of the Company is to bring medical excellence as many potential patients, by applying the latest technology and the most advanced scientific knowledge.
The company also offers online services in different specialties medical imaging diagnosis, through its own platform, such as radiology, cardiology, ophthalmology and dermatology. These services allow relocate the report of the specialist center where the test is performed.
ATRYS carries out an integrated management of oncological disease, from individualized diagnosis (pathology, molecular, genetic and radiological) to the hypo-fractionated radiotherapy or single dose patients likely to benefit from this treatment, through collaborative arrangements management centers reference health.
The company, whose headquarter is located in Madrid, has two main laboratories, equipped with equipment and technologies needed for diagnosis and research, located in Barcelona and Granada Genyo Center.
Also, ATRYS develops projects of applied R & D that have generated several patent families, in collaboration with centers of national and international reference, aimed at improving diagnostic systems and treatment modalities, which allows the company to incorporate latest scientific advances to their clinical practice.
The ATRYS business model is based on four pillars:
The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties, it is required a prior and express permission from BME Market Data. Please contact us at email@example.com.
What is MaB
Financing for companies
MaB for investors
News and Publications
If an issue occurs, the message "TRADING" will change to "MARKET ISSUE" to reflect that a market event has occurred. By clicking on the Issue of the published alert it will be possible to access the information and intraday updates associated with this incident, which will be published immediately.
Note: BME will use its discretion to assign the severity of an incident